Literature DB >> 33396443

Disruption of 24-Hour Rhythm in Intraocular Pressure Correlates with Retinal Ganglion Cell Loss in Glaucoma.

Vladimir Neroev1, Tatyana Malishevskaya1, Dietmar Weinert2, Sergei Astakhov3, Sergey Kolomeichuk4, Germaine Cornelissen5, Yana Kabitskaya6, Elena Boiko6, Irina Nemtsova7, Denis Gubin8,9.   

Abstract

Parameters of 24-h rhythm in intraocular pressure (IOP) were assessed in patients with stable or advanced primary open-angle glaucoma (S-POAG/A-POAG) and referenced to the phase of "marker" circadian temperature rhythm of each patient. Body temperature and IOP were measured over a 72-h span in 115 participants (65 S-POAG and 50 A-POAG). Retinal Ganglion Cell (RGC) damage was assessed by high-definition optical coherence tomography. The 24-h IOP rhythm in A-POAG patients peaked during the night, opposite to the daytime phase position in S-POAG patients (p < 0.0001). The 24-h IOP phase correlated with RGC loss (p < 0.0001). The internal phase shift between IOP and body temperature gradually increased with POAG progression (p < 0.001). Angiotensin converting enzyme Alu-repeat deletion/insertion (ACE I/D) emerged as a candidate gene polymorphism, which may play a role in the alteration of the circadian IOP variability in advanced glaucoma. To conclude, a reliable estimation of the 24-h rhythm in IOP requires the degree of RGC damage to be assessed. In advanced POAG, the 24-h phase of IOP tended to occur during the night and correlated with RGC loss, being progressively delayed relative to the phase of temperature.

Entities:  

Keywords:  angiotensin converting enzyme gene; circadian; glaucoma; intraocular pressure; optical coherence tomography; retinal ganglion cells; temperature

Year:  2020        PMID: 33396443     DOI: 10.3390/ijms22010359

Source DB:  PubMed          Journal:  Int J Mol Sci        ISSN: 1422-0067            Impact factor:   5.923


  1 in total

1.  Melatonin, circadian rhythms and glaucoma: current perspective.

Authors:  Denis Gubin; Dietmar Weinert
Journal:  Neural Regen Res       Date:  2022-08       Impact factor: 5.135

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.